D06623 | |
D number | D06623 |
Classification | Drug |
Name | Olanzapine pamoate (USAN); Olanzapine pamoate monohydrate |
Component | - |
Formula | C23H16O6. C17H20N4S. H2O |
Exact mass | 718.2461 |
Mol weight | 718.8173 |
Structural formula | ![]() |
Sequence | - |
Sequence type | - |
Source | - |
Upper DGroup | Cardiovascular agent DG01466 Adrenergic receptor antagonist DG01465 alpha-Adrenergic receptor antagonist DG01457 alpha1-Adrenergic receptor antagonist Neuropsychiatric agent DG01478 Dopamine antagonist DG01474 Dopamine D2-receptor antagonist DG01475 Dopamine D3-receptor antagonist DG01476 Dopamine D4-receptor antagonist Anti-allergic agent DG01557 Histamine receptor antagonist DG01482 Histamine receptor H1 antagonist Cyp substrate DG01892 CYP1A2 substrate DG01644 CYP2D6 substrate |
Remark | ATC code: N05AH03 Chemical group: DG00898 |
Activity | - |
Disease | - |
Comment | Multi-acting-receptor-targeting-antipsychotics (MARTA) Treatment of schizophrenia |
Target | HTR2 [HSA:3356 3357 3358] [KO:K04157]; HTR6 [HSA:3362] [KO:K04162]; HRH1 [HSA:3269] [KO:K04149]; ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]; DRD2 [HSA:1813] [KO:K04145]; DRD3 [HSA:1814] [KO:K04146]; DRD4 [HSA:1815] [KO:K04147] |
Metabolism | Enzyme: CYP1A2 [HSA:1544]; CYP2D6 [HSA:1565] |
Interaction | |
Other DBs | CAS: 221373-18-8 PubChem: 47208274 DrugBank: DB00334 LigandBox: D06623 |
KCF data | - |